Is topiramate a potential therapeutic agent for cerebral hypoxic/ischemic injury?
Authors:
- Won-Ki KimWKWon-Ki Kim
- 1 January 2007
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 203 (1) , 5-7
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Multiple Mechanisms Underlying the Neuroprotective Effects of Antiepileptic Drugs Against In Vitro IschemiaStroke, 2006
- Topiramate and its clinical applications in epilepsyExpert Opinion on Pharmacotherapy, 2006
- Topiramate reduces AMPA‐induced Ca2+ transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary culturesJournal of Neurochemistry, 2005
- Topiramate in migraine prophylaxisNeurological Sciences, 2005
- Topiramate: A New Potential Pharmacological Treatment for Obesity*Obesity Research, 2004
- Glutamate Receptor-Mediated Oligodendrocyte Toxicity in Periventricular Leukomalacia: A Protective Role for TopiramateJournal of Neuroscience, 2004
- Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal–astroglial culturesEpilepsy Research, 2003
- Topiramate as a neuroprotectant in a rat model of global ischemia-induced neurodegenerationLife Sciences, 2001
- Topiramate as an Inhibitor of Carbonic Anhydrase IsoenzymesEpilepsia, 2000
- Pathobiology of ischaemic stroke: an integrated viewTrends in Neurosciences, 1999